Mic Capital Management Uk LLP Recursion Pharmaceuticals, Inc. Transaction History
Mic Capital Management Uk LLP
- $659 Million
- Q4 2024
A detailed history of Mic Capital Management Uk LLP transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Mic Capital Management Uk LLP holds 9,644,033 shares of RXRX stock, worth $105 Million. This represents 9.89% of its overall portfolio holdings.
Number of Shares
9,644,033
Previous 8,451,758
14.11%
Holding current value
$105 Million
Previous $55.7 Million
17.05%
% of portfolio
9.89%
Previous 8.43%
Shares
3 transactions
Others Institutions Holding RXRX
# of Institutions
338Shares Held
284MCall Options Held
2.83MPut Options Held
3.64M-
Vanguard Group Inc Valley Forge, PA34MShares$370 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$352 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$270 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$188 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$159 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.96B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...